KENNEWICK, Wash., Dec. 18, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotope Corporation (AMIC) (Other OTC:ADMD.PK - News) is currently in formal negotiations to partner with a firm headquartered in China to export isotopes as well as to produce shorter-lived isotopes in both Taiwan and Mainland China. This will provide the benefits of both higher volume availability as well as greater treatment options utilizing different medical isotope production methods currently being developed by AMIC.

Dr. Robert Schenter, AMIC Chief Science Officer, lectured several years ago in Taiwan concerning Brachytherapy for Prostate Cancer and ``Smart Bullets'' (precisely-targeted radioisotopes to kill cancer cells without harming the healthy cells) and was recently consulted to provide an update concerning medical isotopes, nuclear medicine, and the abilities of Advanced Medical Isotope Corporation to assist in the growing health issues of Taiwan and Mainland China.

``Taiwan and Mainland China are two strategic countries with which we anticipate further partnerships, and our current negotiations with forward-looking Health Care providers as well as with other Life Science Companies appear to be evolving into solid financial opportunities. According to the recent Global Cancer Facts & Figures report, in China alone more than 350 million people smoke -- more than the entire population of the United States. Enhancing the quality of life for the citizens of both of these countries is a mandate that practicing doctors in these areas insist upon, and Advanced Medical Isotope Corporation is in a unique position to assist them in fulfilling that mandate,'' stated Marishka Pilch, International Sales and Marketing Director for AMIC.

About AMIC

Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotope Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit http://www.isotopia.us

Forward-Looking Statements

Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely developments and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.

          Advanced Medical Isotope Corporation
          James C. Katzaroff
          (509) 736-4000
          Fax: (509) 736-4007